Accurex Biomedical Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 17-07-2024
- Paid Up Capital ₹ 1.35 Cr
as on 17-07-2024
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.07 Cr
as on 17-07-2024
- Satisfied Charges ₹ 7.40 Cr
as on 17-07-2024
- Revenue 0.83%
(FY 2023)
- Profit -163.63%
(FY 2023)
- Ebitda -122.83%
(FY 2023)
- Net Worth -16.64%
(FY 2023)
- Total Assets 11.09%
(FY 2023)
About Accurex Biomedical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.35 Cr.
The company currently has active open charges totaling ₹13.07 Cr. The company has closed loans amounting to ₹7.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Abhinav Thakur, Savita Thakur, and Anishka Thakur serve as directors at the Company.
- CIN/LLPIN
U85195MH1994PTC080801
- Company No.
080801
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Accurex Biomedical Private Limited offer?
Accurex Biomedical Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit, Clinical Reagents, Diagnostic Reagents, IVDs & Analyzers, Hematology Analyzers, Cell Counter, Test Strips, Urine Test Strip, Biochemistry Analyzer.
Who are the key members and board of directors at Accurex Biomedical?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhinav Thakur  | Managing Director | 16-Feb-2004 | Current |
| Savita Thakur | Managing Director | 25-Jan-2004 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anishka Thakur | Director | 12-May-2022 | Current |
Financial Performance of Accurex Biomedical.
Accurex Biomedical Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.83% increase. The company also saw a substantial fall in profitability, with a 163.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accurex Biomedical?
In 2023, Accurex Biomedical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Dec 2005 | ₹11.07 Cr | Open |
Union Bank Of India Creation Date: 29 Mar 2004 | ₹2.00 Cr | Open |
Others Creation Date: 16 Sep 2016 | ₹1.90 Cr | Satisfied |
How Many Employees Work at Accurex Biomedical?
Accurex Biomedical has a workforce of 202 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accurex Biomedical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accurex Biomedical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
